BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weng J, Wang X, Xu B, Li W. Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway. Exp Ther Med 2021;22:863. [PMID: 34178136 DOI: 10.3892/etm.2021.10295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Morsy MA, Abdel-Gaber SA, Rifaai RA, Mohammed MM, Nair AB, Abdelzaher WY. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression. Biomed Pharmacother 2022;145:112374. [PMID: 34915671 DOI: 10.1016/j.biopha.2021.112374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]